Results 211 to 220 of about 339,306 (357)

Antigen‐specific cancer immunotherapy using a GM‐CSF secreting allogeneic tumor cell‐based vaccine

, 2000
Edwin Y. Chang, Chien‐Hung Chen, Hongxiu Ji, Tian‐Li Wang, Kenneth E. Hung, Bruce P. Lee, Alex Y. Huang, Robert J. Kurman, Drew M. Pardoll, T.‐C. Wu   +9 more
openalex   +1 more source

Cryo‐Inactivated Cancer Cells Derived Magnetic Micromotors for Tumor Immunotherapy

Advanced Science, EarlyView.
Cryo‐inactivated cancer cell‐based magnetic micromotors are developed for synergistic tumor immunotherapy via magnetic targeting. These micromotors can induce ferroptosis and immunogenic cell death, deliver tumor antigens, and activate the Mn2+‐dependent cGAS‐STING pathway. The system effectively suppresses tumor progression, recurrence, and metastasis,
Qingfei Zhang, Gaizhen Kuang, Wenzhao Li, Yuanjin Zhao   +3 more
wiley   +1 more source

Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience [PDF]

, 2001
Cristina Musselli, Philip O. Livingston, Govindaswami Ragupathi   +2 more
openalex   +1 more source

Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy

Advanced Science, EarlyView.
This study employs neutrophils for the precise delivery of anti‐CD47 antibodies, combined with bacterial outer membrane vesicles, to enhance macrophage phagocytic function in the tumor microenvironment. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and ...
Meng Guan, Xiao‐Ting Xie, Dong Zhou, Kai Cheng, Bin Zhang, Xin‐Yue Xu, Yong Li, Yi‐Tong Zhou, Wei Peng, Li‐Li Chen, Peng‐Shuo Dong, Si Chen, Jia‐Hua Zou, Bo Liu, Yuan‐Di Zhao, Jin‐Xuan Fan   +15 more
wiley   +1 more source

Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction [PDF]

, 2001
Isabelle Miconnet, Isabelle Coste, Friedrich Beermann, Jean‐François Haeuw, Jean‐Charles Cerottini, Jean‐Yves Bonnefoy, Pedro Romero, Toufic Renno   +7 more
openalex   +1 more source

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi‐institutional study

Annals of Gastroenterological Surgery, EarlyView.
The six autoantibodies (Sui1, p62, RalA, p53, NY‐ESO‐1 and c‐myc) positive group had poor prognosis compared to autoantibody negative group. A panel of autoantibodies against a tumor associated antigen in esophageal cancer patients had an additive effect with SCC‐Ag to detect esophageal SCC even in early stage.
Fumiaki Shiratori, Naoto Fujiwara, Yasuaki Nakajima, Koji Otsuka, Masahiko Murakami, Satoru Matsuda, Hirofumi Kawakubo, Keita Takahashi, Yuichiro Tanishima, Daiji Oka, Shunichi Ito, Kosuke Narumiya, Osamu Aramaki, Tadatoshi Takayama, Takashi Suzuki, Satoshi Yajima, Hideaki Shimada   +16 more
wiley   +1 more source

Cervical cancer vaccines: Emerging concepts and developments

, 2001
Diane M. Da Silva, Gretchen L. Eiben, Steven C. Fausch, Mark T. Wakabayashi, Michael P. Rudolf, Markwin P. Velders, W. Martin Kast   +6 more
openalex   +2 more sources

Shared neoantigens' atlas for off-the-shelf cancer vaccine development. [PDF]

J Transl Med
Mauriello A, Cavalluzzo B, Ragone C, Tagliamonte M, Buonaguro L.   +4 more
europepmc   +1 more source

Creating therapeutic cancer vaccines: notes from the battlefield [PDF]

, 2001
Willem W. Overwijk, Nicholas P. Restifo
openalex   +1 more source

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

Aggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail, Guangze Yang, Yilong Fan, Yue Hui, Chun‐Xia Zhao, Yun Liu   +5 more
wiley   +1 more source